ZTS
Zoetis Inc
NYSE: ZTS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$113.83
-2.42% today
Updated 2026-04-29
Market cap
$48.05B
P/E ratio
18.91
P/S ratio
5.08x
EPS (TTM)
$6.02
Dividend yield
1.71%
52W range
$113 – $170
Volume
3.8M
Zoetis Inc (ZTS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+5.3%
Last 4 quarters
Revenue YoY growth
+3.0%
Most recent quarter
EPS YoY growth
+5.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.2%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-13.6%
2025-11-03
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-12 | $1.48 | +5.7% | $128.67 | $126.65 | -1.6% |
| 2025-11-03 | $1.70 | +3.7% | $144.09 | $124.46 | -13.6% |
| 2025-08-05 | $1.61 | +5.9% | $151.81 | $146.50 | -3.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $1.40 | $1.48 | +5.7% | $2.39B | +3.0% |
| 2025-09-30 | $1.64 | $1.70 | +3.7% | $2.40B | +0.5% |
| 2025-06-30 | $1.52 | $1.61 | +5.9% | $2.46B | +4.2% |
| 2025-03-31 | $1.40 | $1.48 | +5.7% | $2.22B | +1.4% |
| 2024-12-31 | $1.36 | $1.40 | +2.9% | $2.32B | +4.7% |
| 2024-09-30 | $1.46 | $1.58 | +8.2% | $2.39B | +11.0% |
| 2024-06-30 | $1.49 | $1.56 | +4.7% | $2.36B | +8.3% |
| 2024-03-31 | $1.34 | $1.38 | +3.0% | $2.19B | — |
| 2023-12-31 | $1.32 | $1.24 | -6.1% | $2.21B | — |
| 2023-09-30 | $1.36 | $1.36 | +0.0% | $2.15B | — |
| 2023-06-30 | $1.32 | $1.41 | +6.8% | $2.18B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $7.08 | $10.0B | +5.7% | 11 | high |
| 2027 (E) | $7.62 | $10.5B | +4.9% | 11 | high |
| 2028 (E) | $8.15 | $11.1B | +5.3% | 11 | medium |
| 2029 (E) | $8.68 | $11.7B | +5.7% | 11 | medium |
| 2030 (E) | $9.24 | $12.3B | +5.6% | 11 | medium |
Frequently asked questions
Has Zoetis Inc beaten earnings estimates?
Zoetis Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +5.3% over the last 4 quarters.
How does ZTS stock react to earnings?
ZTS stock has moved an average of -6.2% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is Zoetis Inc's revenue growth rate?
Zoetis Inc reported year-over-year revenue growth of +3.0% in its most recent quarter, with EPS growing +5.7% year-over-year.
What is the expected EPS for ZTS in 2026?
Analysts expect Zoetis Inc to report EPS of $7.08 for fiscal year 2026, on revenue of $10.0B, based on estimates from 11 analysts.